The Latest Cannabis Articles from Streetwise Reports


Cannabis Firm Posts Improved Q2 FY22 YOY

Research Report
  ()
Compared to the previous year, the company's overall operating results for the quarter are better, noted a Noble Capital Markets report.
Tags:  Cannabis

Cannabis Firm Increases YOY Revenue By 352% in 2021

Research Report
  ()
The company is expected to outperform again in 2022 given its focus on strategic growth and acquisitions, noted a Noble Capital Markets report.
Tags:  Cannabis

Cannabis Infused Beverage Company Stock in 'Very Good Spot' to Purchase

Contributed Opinion
  ()
Technical analyst Clive Maund explains why he rates this company a strong speculative buy.
Tags:  Cannabis

Q1 Results of Cannabis Firm Down YoY

Research Report
  ()
Despite a dampened Q1 FY22 performance and an uncertain future, parts of a cannabis firm's story remain attractive, warranting a Market Perform rating, noted a Noble Capital Markets report.
Tags:  Cannabis

Cannabis Cos. Expected to Post Better Revenues As of Q2/22

  ()
Whereas U.S. multistate cannabis operators are expected to do well in 2022, federal legalization of cannabis would give a jolt to companies of all sizes, noted a ROTH Capital Partners report.
Tags:  Cannabis

GNC to Distribute Products for CBD Co.

Research Report
  ()
The agreement with GNC is a step toward Charlotte's Web Holdings' goals of expanding consumer access to its products and becoming cash flow positive this year, noted a ROTH Capital Partners report.
Tags:  Cannabis

US Cannabis Firm in 'State of Flux'

Research Report
  ()
With several market factors working against Stem Holdings, its future is uncertain, noted a Noble Capital Markets report.
Tags:  Cannabis

Showing Results: 1 to 7 of 7

Get Our Streetwise Reports Resources Report Newsletter Free and be the first to know!

A valid email address is required to subscribe